Similar Articles
When should we think of immunodeficiency?
Okan Özçeker, Utku Ateş
DOI: 10.5606/fng.btd.2016.055
Issue: 2016, Volume 2 - Issue 4
0
1043
Examination of the effect of clinical care maps on the deviations which may occur on the scheduled standard treatment process: a hospital example
Birkan Tapan, Nurdan Yıldırım, Selin Alıcı
DOI: 10.5606/fng.btd.2015.004
Issue: 2015, Volume 1 - Issue 1
0
1656
Effect of lactate dehydrogenase activity on hair follicle stem cell
Çağrıhan Ceyhan, Suzan Düzkar, Oğuzhan Kandemir, Mesut Özgün Özdal, Oytun Erbaş
DOI: 10.5606/fng.btd.2017.028
Issue: 2017, Volume 3 - Issue 4
0
1277
Autosomal recessive spastic ataxia of Charlevoix-Saguenay
Tural Mammadov, Bülent Aslan, Cemal Aydın Gündoğmuş, Halil İbrahim Sever, Nagihan İnan Gürcan, Gazanfer Ekinci
DOI: 10.5606/fng.btd.2021.64
Issue: 2021, Volume 7 - Issue 2
814
1285
Platelet mediated cancer modulation: A comprehensive review from biological mechanisms
Fatime Akgeyik, Alper Demirezen, Oytun Erbaş
DOI: 10.5606/fng.btd.2023.135
Issue: 2023, Volume 9 - Issue 3
611
489
PTENopathy: A review on pathology, mechanisms, and treatment strategies
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/fng.btd.2023.136
Issue: 2023, Volume 9 - Issue 3
574
430
Glioblastoma multiforme: Subtypes based on IDH, ATRX, H3F3A, MGMT and p53 mutations
Fatime Akgeyik, Alper Demirezen, Oytun Erbaş
DOI: 10.5606/fng.btd.2024.144
Issue: 2024, Volume 10 - Issue 1
637
331
Genetically engineered mice models and generating glioblastoma multiforme in the brain
Yasin Polat, Oytun Erbaş
DOI: 10.5606/fng.btd.2024.147
Issue: 2024, Volume 10 - Issue 1
467
310